Topical Pain Relief Market Size, Share, and Growth Analysis, By Therapeutic Classes (Non-opioids, Opioids), By Formulation (Cream, Gel), By Gender, By Age Group, By Type, By Distribution Channel, By Region - Industry Forecast 2025-2032
Mylan N.V.(now part of Viatris Inc.)(United States)
AdvaCare Pharma(United States)
Topical Biomedics Inc.(United States)
°á·Ð°ú Á¦¾È
LSH
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
Global Topical Pain Relief Market size was valued at USD 11.2 billion in 2023 and is poised to grow from USD 12.02 billion in 2024 to USD 21.12 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).
The rising prevalence of arthritis is a key factor driving the growth of the topical pain relief market, alongside an expanding elderly population and increased use among athletes. According to a comprehensive global market report, the industry experiences significant momentum due to rising cases of arthritis, bone disorders, diabetic neuropathy, and cancer-associated discomfort. Topical pain relief products are favored for their reduced side effects compared to oral medications. However, challenges such as potential skin irritation and unpleasant odors could hinder market progress. Nevertheless, the growth of online distribution channels and untapped markets in developing regions present promising opportunities for expansion. This evolving landscape highlights both the challenges and potential avenues for growth in the topical pain relief sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Topical Pain Relief Market Segments Analysis
Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Topical Pain Relief Market
The increasing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, serves as a significant catalyst for the growth of the global topical pain relief market. As more individuals experience these persistent health issues, there is an rising demand for effective, localized pain management options. Consumers are increasingly inclined towards solutions that provide both convenience and targeted relief, which topical treatments can offer. This trend highlights the importance of developing innovative and user-friendly products that cater to the specific needs of patients, driving market expansion and creating opportunities for companies in this sector.
Restraints in the Global Topical Pain Relief Market
Although topical pain relief products are commonly utilized, a significant restraint in the global market lies in the lack of comprehensive clinical evidence supporting their efficacy and safety. This gap in research affects consumer trust and can hinder the widespread adoption of these products. The uncertainty surrounding their performance may lead potential users to seek alternative pain relief options, thereby limiting market growth. Strengthening clinical trials and providing clearer data on the effectiveness and safety profiles of topical pain relief formulations are essential strategies that need to be addressed to enhance consumer confidence and encourage greater market acceptance.
Market Trends of the Global Topical Pain Relief Market
The Global Topical Pain Relief market is experiencing a notable trend towards the use of natural and herbal ingredients in its products, driven by a growing consumer preference for wellness-oriented solutions. As awareness of the potential side effects associated with synthetic components rises, more individuals are seeking topical pain relief options that prioritize natural formulations. This shift is not only indicative of a broader demand for cleaner, greener health products but also reflects an emerging inclination towards holistic approaches to pain management. Consequently, manufacturers are pivoting to incorporate organic, plant-based ingredients, aligning with consumer interests in sustainability and superior health benefits.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Customer And Buying Criteria Analysis
Regulatory Analysis
Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2025-2032)
Market Overview
Non-opioids
Nonsteroidal anti-inflammatory drug (NSAIDS)
Methyl salicylates
Capsaicin
Lidocaine
Other non-opioids
Opioids
Buprenorphine
Fentanyl
Global Topical Pain Relief Market Size by Formulation & CAGR (2025-2032)
Market Overview
Cream
Gel
Spray
Patch
Others
Global Topical Pain Relief Market Size by Gender & CAGR (2025-2032)
Market Overview
Women
Men
Global Topical Pain Relief Market Size by Age Group & CAGR (2025-2032)
Market Overview
Adults (18-64 Years)
Geriatric (65 Years and Above)
Global Topical Pain Relief Market Size by Type & CAGR (2025-2032)
Market Overview
Prescription Pain Relief
Over the Counter (OTC) Pain Relief
Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Pharmacy and Drug Stores
Retail Stores
Online Stores
Global Topical Pain Relief Market Size & CAGR (2025-2032)
North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
US
Canada
Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Johnson & Johnson (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
GlaxoSmithKline plc (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Novartis AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Pfizer Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Reckitt Benckiser Group plc (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Sun Pharmaceutical Industries Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Endo International plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Sanofi S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Mylan N.V. (now part of Viatris Inc.) (United States)